MARKET

AXDX

AXDX

Accelerate
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.88
+0.36
+2.32%
After Hours: 15.88 0 0.00% 16:00 12/06 EST
OPEN
15.63
PREV CLOSE
15.52
HIGH
15.99
LOW
15.47
VOLUME
281.30K
TURNOVER
--
52 WEEK HIGH
24.00
52 WEEK LOW
10.23
MARKET CAP
867.76M
P/E (TTM)
-10.1418
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AXDX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AXDX News

  • Accelerate Diagnostics to Participate in 31st Annual Piper Jaffray Healthcare Conference in New York on December 4, 2019
  • PR Newswire.4d ago
  • Accelerate Diagnostics Announces Executive Transition: Lawrence Mehren to Retire as Chief Executive Officer; Jack Phillips Appointed as Successor
  • Benzinga.4d ago
  • Accelerate Diagnostics Announces Executive Transition: Lawrence Mehren to Retire as Chief Executive Officer; Jack Phillips Appointed as Successor
  • PR Newswire.4d ago
  • Is Accelerate Diagnostics, Inc.'s (NASDAQ:AXDX) CEO Paid Enough Relative To Peers?
  • Simply Wall St..6d ago

More

Industry

Advanced Medical Equipment & Technology
+0.79%
Healthcare Equipment & Supplies
+0.59%

Hot Stocks

Name
Price
%Change

About AXDX

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit.
More

Webull offers Accelerate Diagnostics Inc (AXDX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.